Clinical Trial Update: Pneumococcal Adult-dose Ranging Immunization Study [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating an adult-dose pneumococcal immunization for pneumonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Snippet

Sponsor: Kaiser Permanente | Conditions: Pneumonia | Phase 1, Phase 2 | Status: COMPLETED